An intact HDM2 RING-finger domain is required for nuclear exclusion of p53

被引:0
|
作者
Scott D. Boyd
Kenneth Y. Tsai
Tyler Jacks
机构
[1] MIT Center for Cancer Research,Department of Biology Massachusetts Institute of Technology
[2] Harvard-MIT Division of Health Sciences Technology,undefined
[3] Howard Hughes Medical Institute,undefined
来源
Nature Cell Biology | 2000年 / 2卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The p53 tumour-suppressor protein is negatively regulated by HDM2. Recent reports indicate that the leucine-rich nuclear-export sequence (NES) of HDM2 enables it to shuttle to the cytoplasm, and that this activity is required for degradation of p53. However, it is unclear whether HDM2 is involved in nuclear export of p53, partly because p53 has itself been shown to contain a functional NES within its tetramerization domain. Here we show that co-expression of HDM2 with green fluorescent protein (GFP)-tagged p53 causes redistribution of p53 from the nucleus to the cytoplasm of the cell. This activity is dependent on binding of p53 to HDM2, and requires an intact p53 NES, but is independent of the HDM2 NES. A mutant of the HDM2 RING-finger domain that is unable to ubiquitinate p53 does not cause relocalization of p53, indicating that ubiquitin ligation or other activities of this region of HDM2 may be necessary for its regulation of p53 localization.
引用
收藏
页码:563 / 568
页数:5
相关论文
共 50 条
  • [1] An intact HDM2 RING-finger domain is required for nuclear exclusion of p53
    Boyd, SD
    Tsai, KY
    Jacks, T
    NATURE CELL BIOLOGY, 2000, 2 (09) : 563 - 568
  • [2] The MDM2 RING-finger domain is required to promote p53 nuclear export
    Geyer, RK
    Yu, ZK
    Maki, CG
    NATURE CELL BIOLOGY, 2000, 2 (09) : 569 - 573
  • [3] The MDM2 RING-finger domain is required to promote p53 nuclear export
    Rory K. Geyer
    Zhong K. Yu
    Carl G. Maki
    Nature Cell Biology, 2000, 2 : 569 - 573
  • [4] Computational modeling study of the C-terminal ring-finger domain of HDM2
    Hu, ZJ
    Githu, T
    Bowen, D
    Southerland, WM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U785 - U785
  • [5] Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53
    Tao, WK
    Levine, AJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) : 3077 - 3080
  • [6] An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2
    Evans, SC
    Viswanathan, M
    Grier, JD
    Narayana, M
    El-Naggar, AK
    Lozano, G
    ONCOGENE, 2001, 20 (30) : 4041 - 4049
  • [7] Human hdm2/p53 interaction antagonists
    Westwell, AD
    Langston, S
    DRUG DISCOVERY TODAY, 2001, 6 (02) : 102 - 103
  • [8] An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2
    Susan C Evans
    Meena Viswanathan
    Jason D Grier
    Meera Narayana
    Adel K El-Naggar
    Guillermina Lozano
    Oncogene, 2001, 20 : 4041 - 4049
  • [9] Metal and RNA binding properties of the hdm2 RING finger domain
    Lai, ZH
    Freedman, DA
    Levine, AJ
    McLendon, GL
    BIOCHEMISTRY, 1998, 37 (48) : 17005 - 17015
  • [10] Inhibitors of the Hdm2:p53 complex as antitumour agents
    Westwell, AD
    DRUG DISCOVERY TODAY, 2006, 11 (7-8) : 371 - 371